Teladoc Health (NYSE:TDOC) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says

Teladoc Health (NYSE:TDOC) had its target price upped by The Goldman Sachs Group from $14.00 to $16.00 in a research report sent to investors on Tuesday,Benzinga reports. They currently have a buy rating on the health services provider’s stock.

Several other research analysts have also recently commented on TDOC. Piper Sandler reiterated an “overweight” rating and set a $13.00 price target (up previously from $11.00) on shares of Teladoc Health in a report on Wednesday, December 4th. TD Cowen lowered their target price on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a research note on Thursday, October 31st. Deutsche Bank Aktiengesellschaft raised their price target on Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research note on Friday, November 1st. Bank of America upped their price objective on Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research report on Wednesday, February 12th. Finally, Royal Bank of Canada raised their target price on Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Fourteen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $12.18.

Teladoc Health Stock Performance

Shares of TDOC opened at $12.75 on Tuesday. Teladoc Health has a 1 year low of $6.76 and a 1 year high of $16.82. The stock has a market capitalization of $2.19 billion, a PE ratio of -2.21 and a beta of 1.05. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The stock has a 50-day simple moving average of $10.52 and a 200-day simple moving average of $9.41.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of the stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the sale, the insider now directly owns 2,890 shares of the company’s stock, valued at approximately $34,477.70. This trade represents a 45.25 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.95% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Teladoc Health

Several large investors have recently modified their holdings of TDOC. Versant Capital Management Inc increased its stake in Teladoc Health by 313.8% in the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock valued at $29,000 after buying an additional 2,441 shares during the period. Whipplewood Advisors LLC acquired a new position in shares of Teladoc Health during the fourth quarter worth about $29,000. Lindbrook Capital LLC raised its holdings in Teladoc Health by 78.9% during the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock worth $33,000 after purchasing an additional 1,612 shares in the last quarter. Blue Trust Inc. lifted its position in Teladoc Health by 84.5% in the third quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock valued at $40,000 after purchasing an additional 1,854 shares during the period. Finally, Sterling Capital Management LLC boosted its holdings in Teladoc Health by 776.7% in the 4th quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider’s stock valued at $42,000 after purchasing an additional 4,101 shares in the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.